High-grade cervical intra-epithelial neoplasia Cancer Cervical
Conditions
Interventions
Pap testing compared to HPV testing.
Sponsors
McGill University (Canada) - Research Grants Office
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Current inclusion criteria as of 05/01/2010: 1. Women aged 30 to 69 years 2. Sought screening tests for cervical cancer in any of 30 family practice or gynaecology clinics in Montreal and St. John's, Canada Initial inclusion criteria at time of registration: 1. Women aged between 30 and 69 years 2. Currently attending a colposcopy clinic for evaluation, treatment or follow up of a cervical lesion
Exclusion criteria
Exclusion criteria: Current exclusion criteria as of 05/01/2010: 1. Currently being followed up for a cervical lesion 2. Lacked a cervix 3. Pregnant 4. Had a history of cervical cancer 5. Had undergone Pap testing in the previous year 6. Unable to provide consent were excluded (note that this is related also to the ability to understand French or English) Initial exclusion criteria at time of registration: 1. Without a cervix 2. Pregnant 3. History of cervical cancer 4. Known human immunodeficiency virus (HIV) infection 5. Mentally incompetent 6. Unable to understand French or English 7. Refuse to provide an informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biopsy-proven cervical intraepithelial neoplasia (CIN 2, 3) (high grade intraepithelial lesion [HSIL]) or cancer, ascertained at 6, 12, and 18 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Biopsy-proven CIN 1 (low grade intraepithelial lesion [LSIL]) at 18 months. | — |
Countries
Canada
Outcome results
None listed